The National Mental Health Innovation Center (NMHIC) and Oxford VR (OVR) have announced a strategic partnership and the launch of multiple pilots using VR therapy treatment programs to advance mental health outcomes.
The collaboration will involve testing of Oxford’s VR’s suite of automated evidence-based treatment programs, which use leading-edge virtual reality (VR) technology to treat mental health conditions such as fear of heights, social anxiety, depression and OCD and psychosis.
“We thoroughly vet technology companies and look for specific quality metrics. This includes whether or not the technology is backed by research, is scalable, and has the potential for significant clinical impact. OVR meets all of these criteria and approaches mental health innovation with scaling and clinical impact in mind.”
Speaking about the announcement – Mimi McFaul, Deputy Director of NMHIC.
The collaboration involves multiple pilots which aim to increase access to innovative evidence-based psychological therapy treatment programs using virtual reality technology.
“We are very excited to partner with NMHIC which is a world-renowned organization. Our collective vision is to turn the tide on life-interrupting mental illnesses by pushing the boundaries of clinical research excellence and technology to transform outcomes for service users.
Commenting on this significant partnership, Barnaby Perks, co-founder and CEO of OVR.
